Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: scRNA for pansclerotic morphea lesional

PROVIDER: PRJNA1054546 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27284100_1.fastq.gz	Fastqsanger.gz
	SRR27284100_2.fastq.gz	Fastqsanger.gz
	SRR27284101_1.fastq.gz	Fastqsanger.gz
	SRR27284101_2.fastq.gz	Fastqsanger.gz
	SRR27284102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 192

Similar Datasets

scRNA for pansclerotic morphea lesional

Project description:scRNA for pansclerotic morphea lesional

| PRJNA983843 | ENA

Analysis of microarray data of lesional and unaffected skin from morphea patients

Project description:Analysis of microarray data of lesional and unaffected skin from morphea patients

2023-06-01 | GSE153011 | GEO

Gene expression signatures in inflammatory and sclerotic morphea skin and blood distinguishes morphea from systemic sclerosis

Project description:Morphea is an inflammatory disorder of the skin and soft tissue characterized by fibrosis that has been likened to systemic sclerosis (SSc). We sought to capture the molecular heterogeneity of morphea by examining lesional skin gene expression and blood biomarkers, and compare the gene expression profiles with those from SSc lesional and site matched non lesional skin, as well as sera obtained from adult patients with untreated morphea. We found the morphea transcriptome is dominated by IFNg-mediated Th1 immune dysregulation, with relative paucity of pathways associated with fibrosis. These results were mirrored when morphea gene expression profiles were compared with SSc. Interestingly, expression profiles of morphea skin samples clustered with the SSc inflammatory subset and distinct from the SSc fibro-proliferative subset. Unaffected morphea skin also differed from unaffected SSc skin in that it did not exhibit pathological gene expression signatures. Examination of downstream IFNg-mediated chemokines, CXCL9 and CXCL10, revealed increased transcription in the skin but not in sera. While elevated serum CXCL9 proteins quantified by ELISA were associated with active disease and widespread cutaneous disease. Taken together, these results indicate that inflammatory and sclerotic morphea is a skin directed process characterized by Th1 immune mediated dysregulation, which contrasts with fibrotic signatures and systemic transcriptional changes associated with SSc. The association of circulating CXCL9 concentration with clinical activity and burden of skin disease supports its potential as a readily accessible biomarker.

2025-04-13 | GSE201405 | GEO

Analysis of microarray data of lesional and unaffected skin from morphea patients

Project description:Analysis of microarray data of lesional and unaffected skin from morphea patients

| PRJNA641360 | ENA

Esoinophilic fasciitis and morphea share gene signatures of inflammatory cell death, self-DNA recognition, and JAK/STAT signaling

Project description:The pathogenesis of eosinophilic fasciitis (EF) and morphea is poorly understood. We analyzed skin biopsies from EF and morphea patients compared to adult healthy skin (HS) using gene expression profiling, Ingenuity Pathway Analysis, and immunostaining. EF gene expression showed significant overlap with morphea. 51/61 differentially expressed genes (DEG), 80/99 canonical pathways, and 40/51 upstream regulators were shared in EF and morphea. Both conditions exhibited robust T cell activation and cytotoxic signatures despite their pauci-inflammatory histological appearance, suggesting small numbers of T cells may drive injury, inflammation, and fibrosis. EF and morphea shared signatures of necroptosis, self-DNA recognition, cGAS/STING activation, induction of types I, II, and III interferon signaling, and fibrosis. Seven JAK/STAT molecules were significantly upregulated in EF and nine were upregulated in morphea. Compared to HS, TYK2 was the most significant JAK molecule upregulated in EF (p=0.0007) and morphea (p=0.0002). Immunostaining demonstrated activated interferon-related molecules JAK1 and STAT1 in T cells, dendritic cells, and macrophages in both diseases. This study identifies shared molecular mechanisms of EF and morphea and demonstrates strong pathophysiologic similarities between the two diseases. Our findings indicate that targeted inhibition of JAK/STAT molecules and mediators of necroptosis may be beneficial in treating these fibrotic diseases.

2025-05-19 | GSE278882 | GEO

single cell RNA-sequencing of matched lesional and nonlesional skin from vitiligo patients

Project description:We performed scRNA-seq analyses on patient matched lesional and nonlesional skin from viitiligo patients using the 10x genomics platform to examine different cell populations and keratinocyte states that may contribute to vitiligo disease persistence.

2022-05-20 | GSE203262 | GEO

Homo sapiens

Project description:Scleroderma Morphea Normal Fibroblasts

| PRJNA104863 | ENA

CXCL9 links skin inflammation and fibrosis via CXCR3-dependent upregulation of collagen 1a1 in fibroblasts

Project description:We performed a comparative transcriptomics study of murine immune, fibrotic and skin gene expression profiles in subcutaneous bleomycin injection to determine whether this model mirrors human morphea (localized scleroderma).

2024-10-22 | GSE187002 | GEO

Single Cell RNA seq data for fibroblast paper

Project description:In this study we compared 14 healthy and 14 LS samples evaluated by 10X Genomics single cell sequencing. Samples were processed and clustered for DEG analysis. LS = Localized Scleroderma, also called Morphea

2024-10-23 | GSE264508 | GEO

Single-cell transcriptome analysis of CD3+ T lymphocytes from prurigo nodularis lesional skin reveals Th17 polarization

Project description:Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by symmetrically distributed, intensely pruritic nodules of unknown etiology and unmet therapeutic need. The lack of approved therapies and the limited efficacy of off-label treatments reflect the current poor understanding of its pathogenesis. We aimed to comprehensively characterize the phenotypic variation of CD3+ T cells and asses cell-specific gene expression in the lesional skin of patients with PN versus in patients with atopic dermatitis (AD) and in healthy controls (HC). To this end, single-cell RNA sequencing (scRNA-Seq) using 10x Genomics was carried out to compare CD3+ T cells transcriptomic heterogeneity between lesional samples of PN (n=6), AD (n=5) and HC (n=5).

2023-07-08 | GSE213849 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data